• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Chronic Drooling - Pipeline Review, H1 2012 Product Image

Chronic Drooling - Pipeline Review, H1 2012

  • ID: 2141770
  • May 2012
  • 33 pages
  • Global Markets Direct

Chronic Drooling – Pipeline Review, H1 2012

Summary

Global Markets Direct’s, 'Chronic Drooling - Pipeline Review, H1 2012', provides an overview of the Chronic Drooling therapeutic pipeline. This report provides information on the therapeutic development for Chronic Drooling, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Chronic Drooling. 'Chronic Drooling - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note-: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Chronic Drooling.
- A review of the Chronic Drooling products under development by companies and universities/research institutes READ MORE >



List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chronic Drooling Overview
Therapeutics Development
An Overview of Pipeline Products for Chronic Drooling
Chronic Drooling Therapeutics under Development by Companies
Chronic Drooling Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Chronic Drooling Therapeutics – Products under Development by Companies
Chronic Drooling Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Chronic Drooling Therapeutics Development
ORIENT PHARMA CO., LTD.
NeuroHealing Pharmaceuticals Inc.
Chronic Drooling – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
SMT D001 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NH004 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Amisulpride + Moclobemide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Chronic Drooling Therapeutics – Drug Profile Updates
Chronic Drooling Therapeutics - Dormant Products
Chronic Drooling – Product Development Milestones
Featured News & Press Releases
Aug 26, 2011: The Michael J Fox Foundation Grants Second Award To NeuroHealing For Clinical Trial Of NH004 For Sialorrhea Control In Parkinson’s Disease
Dec 10, 2010: NeuroHealing Reports Positive Results From Phase II Study Of NH004 For Treatment Of Sialorrhea
Jun 09, 2009: Interim Results Of Phase II Trial For The Treatment Of Sialorrhea To Be Presented At Movement Disorder Society International Congress June 11th
Sep 24, 2008: NeuroHealing Pharmaceuticals To Present At Drug Repositioning Summit
Feb 19, 2008: NeuroHealing Pharmaceuticals Initiates Phase II Clinical Trial of NH004 for Sialorrhea Control in Parkinson’s Disease Patients
Jan 16, 2008: Summit Plc’s Lead Drug Candidate, SMT D001, Enters Phase II Clinical Trials
Dec 13, 2007: The Michael J. Fox Foundation Awards Funding To NeuroHealing Pharmaceuticals Researchers For A Phase II Clinical Trial Of NH004 For Sialorrhea Control In Parkinson’s Disease Patients
Apr 06, 2006: Biotech angel invests $US500,000 in CNS company
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Chronic Drooling, H1 2012
Products under Development for Chronic Drooling – Comparative Analysis, H1 2012
Number of Products under Development by Companies, H1 2012
Number of Products under Investigation by Universities/Institutes, H1 2012
Comparative Analysis by Late Stage Development, H1 2012
Comparative Analysis by Mid Clinical Stage Development, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
ORIENT PHARMA CO., LTD., H1 2012
NeuroHealing Pharmaceuticals Inc., H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Stage and Molecule Type, H1 2012
Chronic Drooling Therapeutics – Drug Profile Updates
Chronic Drooling Therapeutics – Dormant Products

List of Figures
Number of Products under Development for Chronic Drooling, H1 2012
Products under Development for Chronic Drooling – Comparative Analysis, H1 2012
Products under Development by Companies, H1 2012
Products under Investigation by Universities/Institutes, H1 2012
Late Stage Products, H1 2012
Mid Clinical Stage Products, H1 2012
Assessment by Monotherapy Products, H1 2012
Assessment by Combination Products, H1 2012
Assessment by Route of Administration, H1 2012
Assessment by Stage and Route of Administration, H1 2012
Assessment by Molecule Type, H1 2012
Assessment by Stage and Molecule Type, H1 2012

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos